He, Dan
Hu, Hai
Hong, Liang
Zhang, Luming
Lu, Xuehao
Gu, Wan-jie
Lyu, Jun
Yin, Haiyan
Funding for this research was provided by:
National Natural Science Foundation of China ((82072232, 81871585), (82072232, 81871585), (82072232, 81871585), (82072232, 81871585), (82072232, 81871585), (82072232, 81871585))
Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University, China (JNU1AF-CFTP-2022-a01235, JNU1AF-CFTP-2022-a01235, JNU1AF-CFTP-2022-a01235, JNU1AF-CFTP-2022-a01235, JNU1AF-CFTP-2022-a01235)
Science and Technology Projects in Guangzhou, China (202201020054, 202201020054, 202201020054, 202201020054, 202201020054)
Appropriate Technology of Hunan Health Commission, China (202218015798)
Article History
Received: 5 October 2022
Accepted: 8 March 2023
First Online: 7 April 2023
Declarations
:
: The study was an analysis of a third-party anonymized publicly available database with pre-existing institutional review board (IRB) approval. Data extracted from the MIMIC III database do not require individual informed consent because MIMIC III database research data is publicly available and all patient data are de-identified.
: Not applicable.
: The authors declare that they have no competing financial interests.